Literature DB >> 9041903

Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait.

C G Canning1, J A Alison, N E Allen, H Groeller.   

Abstract

OBJECTIVE: To evaluate the exercise capacity of subjects with mild to moderate Parkinson's disease and determine whether abnormalities in respiratory function and gait affect exercise capacity.
DESIGN: Descriptive. Subjects were categorized according to exercise history, disease severity, and presence/absence of upper airway obstruction. SUBJECTS AND
SETTING: Sixteen volunteers with mild to moderate idiopathic Parkinson's disease attended a university research laboratory. MAIN OUTCOME MEASURES: Subjects performed a maximum exercise test on a cycle ergometer, together with respiratory function tests and a walking test. Peak values for oxygen consumption and work rate were recorded for the maximum exercise test. Measures of respiratory function included spirometry, flow-volume loops, lung volumes, and mouth pressures. Velocity, stride length, and cadence were measured for preferred and fast speeds of walking. The values obtained on each of these tests were compared with published predicted age- and gender-matched normal values.
RESULTS: Peak oxygen consumptions and peak work loads achieved by subjects with Parkinson's disease were not significantly different from normal values, despite evidence of respiratory and gait abnormalities typical of Parkinson's disease. Exercise category was significantly correlated with percent predicted VO2peak (r = .64, p < .01), with sedentary subjects producing lower scores than exercising subjects. There was no significant correlation between disease severity and percent predicted VO2peak.
CONCLUSION: Despite their neurological deficit, individuals with mild to moderate Parkinson's disease have the potential to maintain normal exercise capacity with regular aerobic exercise.

Entities:  

Mesh:

Year:  1997        PMID: 9041903     DOI: 10.1016/s0003-9993(97)90264-1

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  17 in total

1.  Energy cost of spontaneous walking in Parkinson's disease patients.

Authors:  Martina A Maggioni; Arsenio Veicsteinas; Susanna Rampichini; Emiliano Cè; Raffaello Nemni; Giulio Riboldazzi; Giampiero Merati
Journal:  Neurol Sci       Date:  2011-11-01       Impact factor: 3.307

2.  Repeatability of aerobic capacity measurements in Parkinson disease.

Authors:  Leslie I Katzel; John D Sorkin; Richard F Macko; Barbara Smith; Frederick M Ivey; Lisa M Shulman
Journal:  Med Sci Sports Exerc       Date:  2011-12       Impact factor: 5.411

3.  Asymmetrical pedaling patterns in Parkinson's disease patients.

Authors:  Amanda L Penko; Joshua R Hirsch; Claudia Voelcker-Rehage; Philip E Martin; Gordon Blackburn; Jay L Alberts
Journal:  Clin Biomech (Bristol, Avon)       Date:  2014-10-29       Impact factor: 2.063

4.  The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.

Authors:  Piniel Alphayo Kambey; Ma Chengcheng; Guo Xiaoxiao; Ayanlaja Abiola Abdulrahman; Kouminin Kanwore; Iqra Nadeem; Wu Jiao; Dianshuai Gao
Journal:  Metab Brain Dis       Date:  2021-01-28       Impact factor: 3.584

5.  No increased risk of obstructive sleep apnea in Parkinson's disease.

Authors:  Lynn Marie Trotti; Donald L Bliwise
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

6.  Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson's disease.

Authors:  Brenda Jeng; Katie L J Cederberg; Byron Lai; Jeffer E Sasaki; Marcas M Bamman; Robert W Motl
Journal:  Gait Posture       Date:  2020-08-11       Impact factor: 2.840

7.  Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study.

Authors:  Carmine Vitale; Valeria Agosti; Dario Avella; Gabriella Santangelo; Marianna Amboni; Rosaria Rucco; Paolo Barone; Francesco Corato; Giuseppe Sorrentino
Journal:  Neurol Sci       Date:  2012-10-12       Impact factor: 3.307

8.  The Unified Parkinson's Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function.

Authors:  Frederick M Ivey; Leslie I Katzel; John D Sorkin; Richard F Macko; Lisa M Shulman
Journal:  J Rehabil Res Dev       Date:  2012

Review 9.  Long-term effects of exercise and physical therapy in people with Parkinson disease.

Authors:  Margaret K Mak; Irene S Wong-Yu; Xia Shen; Chloe L Chung
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

10.  Lung Function Testing On and Off Dopaminergic Medication in Parkinson's Disease Patients With and Without Dysphagia.

Authors:  Tareq Sawan; Mary Louise Harris; Christopher Kobylecki; Laura Baijens; Michel van Hooren; Emilia Michou
Journal:  Mov Disord Clin Pract       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.